Business of Biotech MVP, Allan Shaw, discusses China's biotech rise from follower to innovator, with increased deal activity and faster trials challenging Western models, despite U.S.-China policy uncertainty. Listen now and subscribe so you never miss an episode!
Current short-acting opioid rescue agents were not designed to counteract oral fentanyl overdoses, and the mismatch can be dangerous, explains Elysium Therapeutics' Tom Jenkins, Ph.D.
Gain valuable insights into the role of sponsor-side clinical operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.
IMMvention Therapeutix partners with Novo Nordisk to develop oral therapies for sickle cell disease. Discover how this partnership and their innovative Bach1 inhibitors could transform treatment.
The rise of SaaS (Software as a Service) has transformed industries, including life sciences, by enabling new possibilities. See how it’s already helping life science organizations around the world today.
Watch to learn about the various levels of intensification, core technologies used in the industry, and the impact of each level on productivity through a monoclonal antibody (mAb) platform.
This website uses cookies to ensure you get the best experience on our website. Learn more
